Chen Yang
Shizi Street
Suzhou, China
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Early-life mitochondrial impact of prenatal DL-PCB exposure: A signal from cord blood mtDNA.
Journal: Ecotoxicology and environmental safety
Published: September 09, 2025
The hotspots and publication trends in glioblastoma and CAR-T immunotherapy: A bibliometric analysis.
Journal: Human vaccines & immunotherapeutics
Published: June 03, 2025
A cancer-specific pipeline uncovers MCM3 as a driver of glioblastoma progression via suppression of the Wnt pathway.
Journal: International journal of biological macromolecules
Published: May 31, 2025
Meta-analysis of multi-center transcriptomic profiles and machine learning reveal phospholipase Cβ4 as a Wnt/Ca²+ signaling mediator in glioblastoma immunotherapy.
Journal: Frontiers in immunology
Published: April 12, 2025
Recombinant Antithrombin Alleviated Pulmonary Injury and Inflammation in LPS-Induced ARDS by Inhibiting IL17a/NF-κB Signaling.
Journal: ImmunoTargets and therapy
Published: November 04, 2024
Lasmiditan and Different Triptans in Menstrual Migraine: A Bayesian Network Meta-analysis.
Journal: Pain and therapy
Published: September 09, 2024
Targeting lipid raft-related stomatin to ameliorate osteoporosis in preclinical models.
Journal: Nature communications
Published: June 13, 2024
A Prospective Randomized Trial of Ropivacaine 5 mg with Sufentanil 2.5 μg as a Test Dose for Detecting Epidural and Intrathecal Injection in Obstetric Patients.
Journal: Journal of clinical medicine
Published: November 15, 2022
TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss.
Journal: Autophagy
Published: March 08, 2022
Gut Metabolite Urolithin A Inhibits Osteoclastogenesis and Senile Osteoporosis by Enhancing the Autophagy Capacity of Bone Marrow Macrophages.
Journal: Frontiers in pharmacology
Published: February 14, 2022
Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways.
Journal: Pharmacological research
Published: September 10, 2021
Last Updated: 09/26/2026